Focus: Chia Tai TianQing is a Chinese pharmaceutical company focused on small-molecule drugs and generics across oncology, respiratory, infectious disease, immunology, and hematology. Based in Lianyungang, the company operates a portfolio of branded generics and pipeline oncology assets.
Profile data last refreshed 7h ago · AI intelligence enriched 3w ago
No open roles listed right now. Follow Chia Tai TianQing Pharmaceutical Group to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
CDK4/6 inhibitor awaiting market entry; copy of established Pfizer franchise with near-term revenue upside.
Help build intelligence for Chia Tai TianQing Pharmaceutical Group
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Chia Tai TianQing Pharmaceutical Group's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Estrogen receptor antagonist in mature market; steady-state revenue generator post-patent expiry.
Tubulin-based antimitotic agent; differentiated mechanism in breast and liposarcoma indications post-exclusivity.
NK1 receptor antagonist supporting oncology patients; foundational supportive care asset in post-exclusivity phase.
GnRH antagonist for hormone-sensitive prostate cancer; awaiting market entry to expand urology franchise.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo